Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ames

Showing results (401-410 of 416) with videos related to

Pageof 42
Sort By:
Menopause (New York, N.Y.)|October 15, 2014
Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause SocietyJoAnn E Manson, Jeffrey M Ames, Marla Shapiro, et al.
Evidence-Based Toxicology|September 6, 2024
Cross-mapping of terms used in chemical risk assessment with those used in systematic review: research protocolCamilla Svendsen, Gro H Mathisen, Gunn E Vist, et al.
NPJ Breast Cancer|December 19, 2023
Endoxifen downregulates AKT phosphorylation through protein kinase C beta 1 inhibition in ERα+ breast cancerSwaathi Jayaraman, Xinyan Wu, Krishna R Kalari, et al.
Breast Cancer Research and Treatment|November 23, 2006
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifenMatthew P Goetz, Stacey K Knox, Vera J Suman, et al.
JAMA|October 8, 2009
Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifenWerner Schroth, Matthew P Goetz, Ute Hamann, et al.
Haematologica|July 28, 2011
Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemiaScott H Kaufmann, Judith E Karp, Mark R Litzow, et al.
Nature|April 21, 2022
Somatic genomic changes in single Alzheimer's disease neuronsMichael B Miller, August Yue Huang, Junho Kim, et al.
Archives of Toxicology|September 9, 2025
Exploring experiences of the regulatory toxicology system: system-level promoters and inhibitors of new approach methodologiesAngela Bearth, Birgit Kopainsky, Lowenna B Jones, et al.
Oncotarget|March 4, 2021
Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumorsNaoko Takebe, Geraldine O'Sullivan Coyne, Shivaani Kummar, et al.
Journal of the National Cancer Institute|December 11, 2014
Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studiesMatthew P Goetz, James X Sun, Vera J Suman, et al.
Pageof 42

Showing results (401-410 of 416) with videos related to

Sort By:
Pageof 42
Menopause (New York, N.Y.)|October 15, 2014
Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause SocietyJoAnn E Manson, Jeffrey M Ames, Marla Shapiro, et al.
Evidence-Based Toxicology|September 6, 2024
Cross-mapping of terms used in chemical risk assessment with those used in systematic review: research protocolCamilla Svendsen, Gro H Mathisen, Gunn E Vist, et al.
NPJ Breast Cancer|December 19, 2023
Endoxifen downregulates AKT phosphorylation through protein kinase C beta 1 inhibition in ERα+ breast cancerSwaathi Jayaraman, Xinyan Wu, Krishna R Kalari, et al.
Breast Cancer Research and Treatment|November 23, 2006
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifenMatthew P Goetz, Stacey K Knox, Vera J Suman, et al.
JAMA|October 8, 2009
Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifenWerner Schroth, Matthew P Goetz, Ute Hamann, et al.
Haematologica|July 28, 2011
Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemiaScott H Kaufmann, Judith E Karp, Mark R Litzow, et al.
Nature|April 21, 2022
Somatic genomic changes in single Alzheimer's disease neuronsMichael B Miller, August Yue Huang, Junho Kim, et al.
Archives of Toxicology|September 9, 2025
Exploring experiences of the regulatory toxicology system: system-level promoters and inhibitors of new approach methodologiesAngela Bearth, Birgit Kopainsky, Lowenna B Jones, et al.
Oncotarget|March 4, 2021
Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumorsNaoko Takebe, Geraldine O'Sullivan Coyne, Shivaani Kummar, et al.
Journal of the National Cancer Institute|December 11, 2014
Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studiesMatthew P Goetz, James X Sun, Vera J Suman, et al.
Pageof 42